ICPbio Début On New Zealand Exchange

May 17, 2006

ICPbio Début On New Zealand Exchange

Statement made by Dr Earl Stevens, Managing Director, ICP Biotechnology Limited

ICP Biotechnology Limited ( BIO ) listed on the New Zealand Exchange today, following the completion of the reverse takeover of publicly listed Australasian Property Holdings Group ( APH ).

Principal shareholders are Managing Director Dr Earl Stevens and his wife Tracey, with 39.8% of the company's equity. Other directors are Roger Gower ( Chairman ) and Alistair Ward.

ICPbio is part of the SciTec Index, which the NZX launched yesterday.

One of New Zealand's longest established biotechnology companies, ICPbio manufactures and markets products for use in animal reproduction, animal health care and the fine biochemicals field.

ICPbio's vision is set on becoming a leading global manufacturer of quality biological products for the biotechnology, animal and human pharmaceutical industries.

Nearly 100% of its products are exported, primarily to North America and Europe, with increasing amounts to Asia and South America.

ENDS

© Scoop Media